Search

Your search keyword '"Marta Llanos"' showing total 4 results
Start Over Author "Marta Llanos" Journal leukemia & lymphoma
4 results on '"Marta Llanos"'

1. Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

Author

Joaquin Herrero, Francisco R García-Arroyo, Antonio Rueda, Cristina Quero, Delvys Rodriguez-Abreu, Ana Blasco, Marta Llanos, María José Casanova, Natividad Martínez-Banaclocha, Jesús Alfaro, David Aguiar, Ruth Alvarez, Luis Merino, Virginia Calvo, and Mariano Provencio

Subjects
Oncology, Bendamustine, Cancer Research, medicine.medical_specialty, business.industry, Follicular lymphoma, Hematology, medicine.disease, Lymphoma, Clinical trial, 03 medical and health sciences, 0302 clinical medicine, Refractory, immune system diseases, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Rituximab, Progression-free survival, business, Prospective cohort study, 030215 immunology, medicine.drug
Abstract

Bendamustine is a drug widely used in the treatment of follicular lymphoma. Although it was initially approved as monotherapy in patients refractory to rituximab [1], better results were obtained w...

Published
2018
Full Text
View/download PDF

2. Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years

Author

José Ignacio Chacón, Ruth Alvarez, Ana Royuela, Francisco R García-Arroyo, Cristina Quero Blanco, Juan Ramón Delgado, Luis de la Cruz, Josep Gumá, Marta Llanos, Fernando Franco, Mariano Provencio, José Gómez-Codina, and Antonio Rueda

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Follicular lymphoma, Kaplan-Meier Estimate, 03 medical and health sciences, 0302 clinical medicine, immune system diseases, Median follow-up, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Neoplasm Metastasis, Lymphoma, Follicular, Neoplasm Staging, Group trial, business.industry, Advanced stage, Antibodies, Monoclonal, Induction chemotherapy, Consolidation Chemotherapy, Induction Chemotherapy, Hematology, medicine.disease, Lymphoma, Regimen, Treatment Outcome, Spain, 030220 oncology & carcinogenesis, Retreatment, business, Follow-Up Studies, 030215 immunology
Abstract

Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma (NHL) and represents ∼35% of all NHLs. In the United States there are estimated to be 3.18 cases per 100,000 populations per ...

Published
2018
Full Text
View/download PDF

3. High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma

Author

Mariano Provencio, Julio Rifá, José Gómez-Codina, Cristina Quero, F. Lobo, Juan Ramón Delgado, Antonio Rueda, Francisco R García-Arroyo, Adolfo Murias, Marta Llanos, Pilar Sabin, and Joaquin Herrero

Subjects
Cancer Research, Pathology, medicine.medical_specialty, business.industry, Angiogenesis, Vascular Endothelial Growth Factor C, High serum, Hematology, Prognosis, medicine.disease, Text mining, Oncology, Vascular endothelial growth factor C, medicine, Humans, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, Neoplasm Staging
Abstract

Angiogenesis has substantial prognostic significance in a variety of lymphoid malignancies [1]. Vascular endothelial growth factor-A (VEGF-A) mediates angiogenesis in both physiological and patholo...

Published
2013
Full Text
View/download PDF

4. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after a new induction regimen in intermediate and high-risk follicular lymphoma patients according to the follicular lymphoma international prognostic index (FLIPI): A multicenter, prospective Phase II trial of Spanish Lymphoma Oncology Group

Author

Ruth Álvarez Cabellos, Francisco R García-Arroyo, Cristina Quero Blanco, Miguel Cruz, Antonio García Sánchez, Antonio Rueda, Josep Gumà-Padrò, José Gómez-Codina, Mariano Provencio, Marta Llanos, Juan Ramón Delgado Pérez, and Luis de la Cruz

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Yttrium-90 Ibritumomab Tiuxetan, business.industry, Follicular lymphoma, Hematology, medicine.disease, Lymphoma, Regimen, International Prognostic Index, Internal medicine, medicine, business
Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results